404575-30-0Relevant academic research and scientific papers
CYCLOPROPANAMINE COMPOUND AND USE THEREOF
-
Paragraph 1519; 1520, (2015/10/28)
The present invention provides a compound having a lysine specific demethylase 1 inhibitory action, and useful as a medicament such as a prophylactic or therapeutic agent for schizophrenia, Alzheimer's disease, Parkinson's disease or Huntington's disease, and the like. The present invention relates to a compound represented by the formula wherein A is a hydrocarbon group optionally having substituent(s), or a heterocyclic group optionally having substituent(s); B is a benzene ring optionally having further substituent(s); R1, R2 and R3 are each independently a hydrogen atom, a hydrocarbon group optionally having substituent(s), or a heterocyclic group optionally having substituent(s); A and R1 are optionally bonded to each other to form, together with the adjacent nitrogen atom, a cyclic group optionally having substituent(s); and R2 and R3 are optionally bonded to each other to form, together with the adjacent nitrogen atom, a cyclic group optionally having substituent(s), or a salt thereof.
PROSTAGLANDIN E RECEPTOR ANTAGONISTS
-
Page/Page column 4, (2010/10/19)
The present invention provides prostaglandin receptor antagonist compounds represented by the general formula I, wherein A, R, R1 and R2 are as defined in the specification.
